Security Snapshot

CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) Institutional Ownership

CUSIP: 21900C308

13F Institutional Holders and Ownership History from Q1 2019 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

133

Shares (Excl. Options)

31.87MFull value: 31,867,104 · shares · 30 Sep 2026

Price

$7.70

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+3,433,419
Value change
+$26,164,389
Number of holders
133
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
78,279,847
SEC-reported price per share
$8.20
Insider filing price
$8.20
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE is tracked under CUSIP 21900C308.
  • 133 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 193 to 133 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $345.48MFull value: $345,476,593 · USD · 30 Jun 2026
    to
    $245.16MFull value: $245,164,381 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 133 institutions filings for Q3 2026.

Open SEC evidence

Security key

21900C308

13F reference period

Q3 2026

13F holders

133

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
CRMD
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Deep Track Capital, LP 7.9% +28% $44,985,125 +$9,454,283 6,274,076 +27% Deep Track Capital, LP 31 Mar 2026
SHAIBATALHAMD AYMEN ABDALKADER 5.9% +1.7% $34,685,018 +$139,018 4,618,511 +0.4% SHAIBATALHAMD AYMEN ABDALKADER 11 Jun 2026
BlackRock, Inc. 7.5% $41,659,221 4,567,897 BlackRock, Inc. 31 Dec 2024
As of 30 Sep 2026, 133 institutional investors reported holding
31.87MFull value: 31,867,104 · shares · 30 Sep 2026
shares of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD). This represents 41% of the company’s total
78.28MFull value: 78,279,847 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
30%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Deep Track Capital, LP 8% 6,274,076 0.81% $48,310,385
VANGUARD CAPITAL MANAGEMENT LLC 3.9% 3,051,570 0% $23,497,089
STATE STREET CORP 3.4% 2,637,468 0% $20,308,504
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,909,979 0% $14,709,730
GOLDMAN SACHS GROUP INC 1.6% 1,249,382 0% $9,620,242
MARSHALL WACE, LLP 1.5% 1,195,422 0.01% $9,204,750
Alyeska Investment Group, L.P. 1.1% 850,000 0.02% $6,545,000
ARMISTICE CAPITAL, LLC 1.1% 836,000 0.22% $6,437,200
VANGUARD PORTFOLIO MANAGEMENT LLC 0.93% 730,455 0% $5,624,504
Trexquant Investment LP 0.92% 719,148 0.04% $5,537,440
Hennion & Walsh Asset Management, Inc. 0.69% 536,909 0.12% $4,134,199
VANGUARD FIDUCIARY TRUST CO 0.57% 448,511 0% $3,453,535
KENNEDY CAPITAL MANAGEMENT LLC 0.52% 407,703 0.06% $3,139,313
RAYMOND JAMES FINANCIAL INC 0.46% 359,047 0% $2,764,663
Empowered Funds, LLC 0.34% 268,323 0.01% $2,066,087
WELLINGTON MANAGEMENT GROUP LLP 0.34% 263,406 0% $2,028,226
COMMONWEALTH EQUITY SERVICES, LLC 0.27% 212,135 0% $1,633,440
Quantinno Capital Management LP 0.25% 197,568 0% $1,521,274
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.22% 174,658 0% $1,344,867
TWO SIGMA INVESTMENTS, LP 0.2% 159,965 0% $1,231,731
BANK OF AMERICA CORP /DE/ 0.2% 158,462 0% $1,220,157
Private Advisor Group, LLC 0.2% 154,755 0% $1,191,620
Swiss National Bank 0.19% 146,800 0% $1,130,360
Wingate Wealth Advisors, Inc. 0.16% 128,002 0.41% $985,615
PROFUND ADVISORS LLC 0.16% 127,465 0.03% $981,481

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
31
Headline period
Q3 2026
Rows shown
1-25 of 31
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 31,867,104 $245,164,381 +$26,164,389 $7.70 133
2026 Q2 44,017,914 $345,476,593 +$23,259,269 $7.85 193
2026 Q1 41,111,645 $279,130,873 -$24,958,090 $6.79 186
2025 Q4 41,963,960 $487,974,048 -$15,316,010 $11.63 200
2025 Q3 43,121,910 $501,528,237 +$101,799,375 $11.63 189
2025 Q2 34,151,234 $420,699,898 +$142,837,808 $12.32 169
2025 Q1 23,724,937 $146,235,596 +$397,499 $6.16 135
2024 Q4 22,893,836 $185,441,545 +$29,955,443 $8.10 126
2024 Q3 19,135,638 $154,655,147 +$21,831,393 $8.08 100
2024 Q2 17,129,390 $74,162,669 -$748,246 $4.33 97
2024 Q1 17,269,642 $73,216,929 -$5,693,027 $4.24 89
2023 Q4 18,742,007 $70,461,032 +$3,045,526 $3.76 101
2023 Q3 17,891,223 $66,197,207 -$5,485,628 $3.70 92
2023 Q2 19,187,043 $76,065,204 +$33,053,416 $3.96 86
2023 Q1 10,770,110 $44,582,136 -$1,863,278 $4.14 64
2022 Q4 11,182,776 $47,050,210 +$1,816,100 $4.22 62
2022 Q3 10,928,271 $31,131,890 -$4,497,215 $2.83 66
2022 Q2 12,425,504 $49,348,797 -$5,601,808 $4.02 69
2022 Q1 13,362,668 $73,354,516 +$1,886,576 $5.48 83
2021 Q4 13,046,114 $59,435,463 +$5,549,733 $4.55 78
2021 Q3 11,793,247 $54,910,109 +$1,590,384 $4.65 75
2021 Q2 11,351,356 $77,873,368 +$3,221,689 $6.86 77
2021 Q1 10,781,064 $107,630,096 +$16,345,897 $9.99 76
2020 Q4 9,261,298 $68,791,909 +$7,239,796 $7.43 74
2020 Q3 8,327,514 $50,205,664 +$9,581,252 $6.03 70
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .